Hereditary Diseases
22
7
8
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
1 terminated out of 22 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (22)
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
Pancreatic Cancer Screening in a Population at High Risk
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community
Embryo Health Study
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Lynch Syndrome in Colorectal Cancer Surgery
UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
Multicenter Analysis of Genomic and Metabolic Data of Neonatal Genetic Diseases
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases
Biomarker for Friedreich's Ataxia (BioFridA)
Assessment Psychological Distress for Cancer Heredity Test
A Social Media Approach to Improve Genetic Risk Communication Phase I
Cord Blood Transplantation in Severe Aplastic Anemia
Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population
Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS)